Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo - Wikidata - awgldk - TriplyDB

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

http://www.wikidata.org/entity/Q35606075

about

Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells Potential Clinical Roles for Metabolic Imaging with Hyperpolarized [1-(13)C]Pyruvate Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring Imaging tumor metabolism using positron emission tomography Metabolic pathways promoting cancer cell survival and growth 2-Hydoxyglutarate: D/Riving Pathology in gLiomaS Hyperpolarization MRI: Preclinical Models and Potential Applications in Neuroradiology.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.Detecting tumor progression in glioma: Current standards and new techniques.The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.From Krebs to clinic: glutamine metabolism to cancer therapy.PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2.Novel Approaches to Imaging Tumor Metabolism Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment.Boramino acid as a marker for amino acid transporters.Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer The Potential of Metabolic Imaging.The Emerging Hallmarks of Cancer Metabolism Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module Radiosynthesis and preliminary biological evaluation of N-(2-[18F]fluoropropionyl)-L-glutamine as a PET tracer for tumor imaging.Glutamine at focus: versatile roles in cancer.Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.Physiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP Synthase.Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis.Biosynthesized Gold Nanoclusters and Iron Complexes as Scaffolds for Multimodal Cancer Bioimaging.Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.Energy sources identify metabolic phenotypes in pancreatic cancer.Brain metastasis: Unique challenges and open opportunities.Understanding the Intersections between Metabolism and Cancer Biology.Metabolic Imaging of Glutamine in Cancer.Glutamine Addiction In Gliomas.Glutamine Metabolism in Cancer: Understanding the Heterogeneity.Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.Metabolic reprogramming in clear cell renal cell carcinoma.Metabolic Reprogramming in Glioma.A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus.Engineering Tumour Cell-Binding Synthetic Polymers with Sensing Dense Transporters Associated with Aberrant Glutamine Metabolism.Asymmetric 18F-fluorination for applications in positron emission tomography.

P2860

Q26750861-F1011272-99CB-4775-9816-E0C7701858F5 Q26750864-213785A2-EBBB-4490-9E5B-F31990A82041 Q26765882-67BCBF38-D381-4D28-9C7E-5E518E9F5C33 Q28085278-EA69CCAD-4CFC-4241-B3BB-6E9425E6E52C Q28086940-E98E0593-6B3F-4A3D-8855-9AC8CAE3D370 Q28087807-CFD4336D-53F6-46E2-8935-646CFDD84A6F Q30364782-6A3414EB-F090-4CED-853B-F23637D6F5B5 Q31115540-E093A30D-A88B-42E1-A787-BB6B7A3292D1 Q31132701-669B2939-45F1-4420-A8A1-23BBBF8089DD Q31156299-E2006AC9-C7A2-45A4-BBF2-7402DB4E2F57 Q33834498-07FEE3BD-7E56-48AB-95E6-141CF7B10A7B Q34498995-1196718D-15DE-40EB-A99E-0FAD6CCCCFDF Q35700192-0432AEAA-76C4-4C34-86FD-E1729B27330C Q35764792-F3C11D95-BFB2-49DE-88D1-B3AB66597D01 Q35927273-96AB4FBD-1B07-406F-8582-A116ED99102E Q36256815-2A8FE28B-B18C-4241-B724-A123EE3D9A92 Q36276935-912F4AF0-0657-42D0-9660-4826AD7F4C74 Q36279031-A59064DB-A890-483B-8DB4-E5E644904291 Q36392626-599FED62-29F3-409C-83DB-FE81303EA7AC Q36468964-F91BBC50-64BA-463F-92D9-1AA99B1A7CF4 Q36858702-125EBB55-7049-4A10-B082-70CD19B319FD Q37376210-37059347-5D6D-45C9-8217-40638B242824 Q38678184-589EFD73-722F-4F19-8D3E-28CCE1370B29 Q38694204-C801FEA4-8979-4E21-B8EA-9C7C7120BCBF Q38708488-EA73D095-BBBA-4C3F-8445-5FF1FB338FA7 Q38727372-9BBDCC26-92C2-4AC8-AD1C-1820790E5E6E Q38817346-2E23699B-894A-4348-AEEE-61BE5B93A880 Q38949887-DB49457B-BA4A-4538-A596-0A28DC68682C Q38959840-246829CA-EA17-4E6C-BC5D-3E2C8895A85A Q39035128-20B70081-9F92-45E1-93C6-8B2A4EFA09FC Q39130440-EFD86D99-8B26-4105-803B-86CE1DD1D44B Q39148570-177DA5EC-6BE1-471F-9B14-B053EC0799B1 Q39172398-3F7E34E7-455E-4412-BE7C-2D0BA57939C7 Q39230796-9A00F282-6A3D-499D-9CC5-3F339A6C736D Q39249420-E30E77A2-172E-4775-B7C5-44895DCFDD26 Q39290307-DBD2EF79-6D81-4D27-9830-9B7CDD762DAD Q39297355-2C554CB5-88C0-47C1-B981-E29CB96F3252 Q40082053-0B2C5D44-6DE6-4BCC-B018-FB5309FF41CF Q41075531-140B2CFA-0E56-4261-A788-D600650067EB Q41174141-392FD124-43DA-437B-94B6-8A7841D1F361

P2860

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

http://www.wikidata.org/entity/Q35606075

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@ast

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@en

type

label

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@ast

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@en

prefLabel

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@ast

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@en

P1433

Q35606075-180E6112-C1D4-4AFA-BB47-E21369FCEC91

P1476

Q35606075-0547FE7D-C809-49AB-B555-B88462CF346B

P2093

Q35606075-06F8A6DD-59A8-4D17-9BC0-58252F1E7EA7

Q35606075-0CB81970-99E0-437D-A2D9-9601F9DDA459

Q35606075-4DAA0C9B-D80C-4F7B-B293-606FE8DCC29C

Q35606075-50016BA7-442D-406D-A899-9FC7A49DADD0

Q35606075-59F2FCD5-6C56-4E16-8296-03F2F18627B6

Q35606075-6141289F-AB4F-46CA-BE50-6E71E8B9E1F4

Q35606075-7045C1B8-7637-4453-A134-848BA2D288A6

Q35606075-A1078B2A-07A6-4991-9A46-0A3C36997632

Q35606075-EC05DB98-4E76-42E9-B9F2-B4C330C04E98

Q35606075-FC1F37D5-26AD-44E4-BA0E-D8AA905545A3

P2860

Q35606075-061FF7D7-625C-4376-BBAD-C5434B816996

Q35606075-0863BA19-6694-4494-AF0B-7E2BD130D27B

Q35606075-1117B554-8BD5-4133-82F4-6AAD983084C4

Q35606075-1435455A-59DB-48D8-B818-2685CD88874F

Q35606075-2046109A-7FB4-4750-B925-10F3F8507B70

Q35606075-2822B9B8-811E-4605-B704-2E524BC73AB1

Q35606075-288955DC-E043-4E23-9D19-D5742FD984F4

Q35606075-2CBCBC79-2DFC-4BAD-AE1D-B7E62B39DFE2

Q35606075-404896FF-5F0C-4637-8301-C120DDE747A0

Q35606075-508EC12B-362E-4BEA-80DF-CCDA2C355395

P304

Q35606075-90DC4D46-D050-4636-8036-9B4E7A71E928

P31

Q35606075-2F6B7C7F-39B2-4BDF-A19D-F8751DB2E013

P356

Q35606075-8F8872AE-23E8-4756-BFA4-B18D43E3827A

P407

Q35606075-D32EE9F6-C615-4DF0-8DC3-40685D01BA2F

P433

Q35606075-8E8AE1B9-17DE-4702-8C49-0198CAB6BD77

P478

Q35606075-0A16157B-A10C-419B-9E42-5C18A51359B5

P50

Q35606075-00AEA13E-F0BD-4647-9169-000EEFF011B5

Q35606075-0337B115-EA75-495F-BC98-0943B1E56033

Q35606075-084A67EE-9E91-41B4-A9B6-165EA93F7358

Q35606075-61BB0FBC-5AA3-4A66-A70D-11AA661F2908

Q35606075-78B9BB89-8A15-475A-9B21-FF189CACC6B1

Q35606075-79FF875E-DC69-46CB-A8B8-DD78494230BF

Q35606075-883B25FE-5C83-4097-87CA-CBD9B97F0FCF

Q35606075-9800D3E6-A11D-47DD-8479-AA54843D56C9

Q35606075-A97F119D-81FD-4F3B-A1BE-2BD7DFFD1C43

P577

Q35606075-1FBA0126-FD96-42F3-B8C7-03827431AA59

P698

Q35606075-FCEBBB1F-627A-4D5C-B0C8-F4F1EB3FC376

P932

Q35606075-A4DD0BD5-43A4-4844-89CC-238E816E431A

P356

SCITRANSLMED.AAA1009

P1433

Science Translational Medicine

P1476

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

@en

P2093

Craig B Thompson

http://www.w3.org/2001/XMLSchema#string

Daniel Rohle

http://www.w3.org/2001/XMLSchema#string

Eric C Holland

http://www.w3.org/2001/XMLSchema#string

Hank F Kung

http://www.w3.org/2001/XMLSchema#string

Hanwen Zhang

http://www.w3.org/2001/XMLSchema#string

Ingo K Mellinghoff

http://www.w3.org/2001/XMLSchema#string

Karl Ploessl

http://www.w3.org/2001/XMLSchema#string

Patrick Zanzonico

http://www.w3.org/2001/XMLSchema#string

Serge Lyashchenko

http://www.w3.org/2001/XMLSchema#string

Sriram Venneti

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the Warburg effect: the metabolic requirements of cell proliferation

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

Brain tumors: a multimodality approach with diffusion-weighted imaging, diffusion tensor imaging, magnetic resonance spectroscopy, dynamic susceptibility contrast and dynamic contrast-enhanced magnetic resonance imaging.

Posttreatment evaluation of central nervous system gliomas.

Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities

PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.

Molecular imaging of gliomas with PET: opportunities and limitations.

P304

274ra17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.AAA1009

http://www.w3.org/2001/XMLSchema#string

P407

P433

274

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Cameron Brennan

Justin R. Cross

Gaspare La Rocca

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25673762

http://www.w3.org/2001/XMLSchema#string

P932

4431550

http://www.w3.org/2001/XMLSchema#string